These data clearly suggest that at least for anthrax toxin and likely for other pathogens including SARS-CoV2, furin-targeting pan protease inhibitors could be used as antiviral agents or be deployed prophylactically in emergency medicine in case of pandemic outbreaks in patients that are suspected or at risk of viral infection. The gene discussed is FURIN; the disease is viral infectious disease.